The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils
Abstract
A pathological hallmark of Alzheimer's disease is the senile plaque, containing beta-amyloid fibrils, microglia and astrocytes. Beta-amyloid fibrils exert a cytotoxic effect on neurons, and stimulate microglia to produce neurotoxins, such as reactive oxygen species. Mononuclear phagocytes, including microglia, express scavenger receptors that mediate endocytosis of oxidized low-density lipoproteins, and adhesion to glucose-modified extra-cellular matrix proteins. Here we report that class A scavenger receptors mediate adhesion of rodent microglia and human monocytes to beta-amyloid fibril-coated surfaces leading to secretion of reactive oxygen species and cell immobilization. Thus, class A scavenger receptors are potential therapeutic targets in Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ clearance involves, in part36, phagocytosis and endocytosis via microglial scavenger receptors (SRs)37,38 and extracellular degradation by Aβ-degrading enzymes6,36.”
From Microglia in neurodegeneration (2018) · cites this paper as [38]
In the citing paper
“SR-A1 is an Aβ-phagocytic receptor37,38 expressed on microglia surrounding Aβ plaques in humans and Aβ-mice.”
From Microglia in neurodegeneration (2018) · cites this paper as [38]
Citations
Cites
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
Activation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314
Characterization of ameboid microglia isolated from developing mammalian brain
Giulian, D., & Baker, T. J. (1986) · Journal of Neuroscience · doi:10.1523/jneurosci.06-08-02163.1986 · Cited by 1,300
Krieger, M., & Krieger, J. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.63.1.601 · Cited by 1,169
Quinn, M. T., Parthasarathy, S., Fong, L. G., & Steinberg, D. I. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.9.2995 · Cited by 1,138
Advanced glycation end products contribute to amyloidosis in Alzheimer disease
Vitek, M. P., Bhattacharya, K., Glendening, J. M., Stopa, E., Vlassara, H., Bucala, R., Manogue, K., & Cerami, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4766 · Cited by 806
Advanced Maillard reaction end products are associated with Alzheimer disease pathology.
Smith, M. A., Taneda, S., Richey, P. L., Miyata, S., Yan, S. D., Stern, D., Sayre, L. M., Monnier, V. M., & Perry, G. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5710 · Cited by 715
Pike, C. J., Walencewicz‐Wasserman, A. J., Kosmoski, J., Cribbs, D. H., Glabe, C. G., & Cotman, C. W. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64010253.x · Cited by 699
Fraser, I. P., Hughes, D. A., & Gordon, S. (1993) · Nature · doi:10.1038/364343a0 · Cited by 341
Jiang, H., Burdick, D., Glabe, C. G., Cotman, C. W., & Tenner, A. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.10.5050 · Cited by 330
Flagged first, then by citations
Research works printed but not linked: 5
- Krieger, M. & Herz, J. A. Rev. Biochem. 63, 601–637 (1994). · DOI
- Narindrasorasak, S. et al. Lab. Invest. 72, 272–282 (1995).
- Elghetany, M. T., Saleem, A. & Ban, K. Annls clin. lab. Sci. 19, 190–195 (1989).
- Christie, R. H., Freeman, M. & Hyman, B. T. Am. J. Path. 148, 399–403 (1996).
- Hartung, H.-P. et al. Lab. Invest. 55, 209–216 (1986).
Cited by
Sorted by citations
Items 601–700 of 723
Silwal, A., House, A., Sandoval, K. E., Vijeth, S., Umbaugh, D. S., Crider, A. M., Mobayen, S., Neumann, W. L., & WITT, K. A. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03482-z · Cited by 8
The Adult Neurogenesis Theory of Alzheimer’s Disease
Abbate, C. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221279 · Cited by 11
Scavenger Receptor and Targeting Strategies
Lokhande, A. S., Jahagirdar, P. S., Dandekar, P. P., & Devarajan, P. V. (2019) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-030-29168-6_10 · Cited by 8
Kumar, R., Pavlov, P. F., & Winblad, B. G. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190695 · Cited by 8
Oxidative Stress in Neuronal Death and Apoptosis
Ceballos-Picot, I. (1997) · Neuroscience intelligence unit · doi:10.1007/978-3-662-22516-5_3 · Cited by 8
The role of macrophage scavenger receptor 1 (Msr1) in prion pathogenesis
Li, B., Chen, M., Aguzzi, A., & Zhu, C. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02061-7 · Cited by 7
The Role of the Immune System in Alzheimer's Disease
Cohen, R. M. (2009) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.7.1.foc28 · Cited by 8
Roles of microglial membranes in Alzheimer's disease
Shin, J., & Lee, J. C. (2020) · Current topics in membranes · doi:10.1016/bs.ctm.2020.08.007 · Cited by 7
Scavenger receptor A in immunity and autoimmune diseases: Compelling evidence for targeted therapy
Xie, Y., Yuan, J., Li, Z., & Hu, F. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2072729 · Cited by 7
Administration of recombinant FOXN1 protein attenuates Alzheimer’s pathology in mice
Zhao, J. X., Zhang, Z., Lai, K. C., & Lai, L. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.07.027 · Cited by 8
Estrés oxidativo y neurodegeneración: ¿causa o consecuencia?
Angoa‐Pérez, M., & Rivas-Arancibia, S. (2007) · Archivos de Neurociencias · Cited by 7
Mechanism of Neuronal Death in Alzheimer’s Disease
Irizarry, M. C. (2002) · Advances in behavioral biology · doi:10.1007/978-0-306-47593-1_23 · Cited by 7
Alzheimer s disease and brain development common molecular pathways
Bowser, R. P. (1998) · Frontiers in bioscience · doi:10.2741/a267 · Cited by 7
Blitzer, R. D., Wong, T., Giovannini, M. G., Pangalos, M. N., Robakis, N. K. R. K., & Landau, E. M. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00340-x · Cited by 7
Yan, X., Li, Q., Wu, S., Jie, L., Li, Y., Zhang, T., Chen, D., & Pan, X. (2023) · Food and Chemical Toxicology · doi:10.1016/j.fct.2023.113775 · Cited by 6
β-Adrenergic Receptor, Amyloid β-Peptide, and Alzheimer's Disease
Wang, D., & Xiang, Y. K. (2011) · Current topics in membranes · doi:10.1016/b978-0-12-384921-2.00010-0 · Cited by 6
ARSD is responsible for carcinoma and amyloidosis of breast epithelial cells
Lin, Y., Fan, L., Zhang, R., Pan, H., & Li, Y. (2022) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2022.151199 · Cited by 6
Chapter 2. Alzheimer's Disease: Recent Advances on the Amyloid Hypothesis
John, V., Latimer, L. H., Tung, J. S., & Dappen, M. S. (1997) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)61460-8 · Cited by 6
Verdier, Y., & Penke, B. (2006) · Current Signal Transduction Therapy · doi:10.2174/157436206775269208 · Cited by 6
Involvement of Free Radicals in the Development and Progression of Alzheimer’s Disease
Rosales‐Hernández, M. C., Rodríguez, M. H., Wejebe, J. E. M., & Correa‐Basurto, J. (2016) · InTech eBooks · doi:10.5772/64708 · Cited by 6
N’Go, P. K., Ahami, O. T. A., Hessni, A. E., Azzaoui, F.-Z., Aboussaleh, Y., & Tako, A. N. (2021) · Translational Neuroscience · doi:10.1515/tnsci-2020-0183 · Cited by 5
Mhatre, M., & Hensley, K. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50155-1 · Cited by 4
Stanyer, L., Betteridge, D. J., & Smith, C. C. T. (2004) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2004.07.005 · Cited by 5
Correction: CD36 Participates in PrP106–126-Induced Activation of Microglia
Kouadir, M., Yang, L., Tan, R., Shi, F., Lu, Y., Zhang, S., Yin, X., Zhou, X., & Zhao, D. (2012) · PLoS ONE · doi:10.1371/annotation/f900d37b-3d36-4551-8680-cecf4bd1418d · Cited by 5
Gordon, S., & Neyen, C. D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.30110-9 · Cited by 5
Lacivita, E., Stama, M. L., Maeda, J., Fujinaga, M., Hatori, A., Zhang, M., Colabufo, N. A., Perrone, R., Higuchi, M., Suhara, T., et al. (2016) · Chemistry & Biodiversity · doi:10.1002/cbdv.201500281 · Cited by 4
The Aβcentric Pathway of Alzheimer’s Disease
Villemagne, V. L., Cappai, R., Barnham, K. J., Cherny, R. A., Opazo, C., Novakovic, K. E., Rowe, C. C., & Masters, C. L. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_2 · Cited by 4
Acidic-rich region of amyloid precursor protein induces glial cell apoptosis
Sun, K., SUN, G.-H., Su, Y., Chang, C., Chuang, M.-J., Wu, W.-L., Chu, C.-Y., & Tang, S. (2004) · APOPTOSIS · doi:10.1023/b:appt.0000045793.44842.e7 · Cited by 4
Two Hits and You’re Out? A Novel Mechanistic Hypothesis of Alzheimer Disease
Zhu, X., Perry, G. L., & Smith, M. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-72076-0_19 · Cited by 4
Dudal, S., Morissette, C., Lacombe, D., Tremblay, P., & Gervais, F. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.04.014 · Cited by 4
Coffee and Alzheimer's Disease: Animal and Cellular Evidence
Miller, M. G., & Shukitt‐Hale, B. (2012) · Wiley eBooks · doi:10.1002/9781119949893.ch4 · Cited by 4
Prahlad, V., & Chikka, M. R. (2018) · Wiley eBooks · doi:10.1002/9781118772034.ch3 · Cited by 4
Burton, E. A., Argenziano, M., Cook, K., Ridler, M., Lu, S., Su, C., Manduchi, E., Littleton, S. H., Leonard, M. E., Hodge, K. M., et al. (2024) · doi:10.1101/2024.08.22.609230 · Cited by 3
Olvera‐Rojas, M., Plaza‐Florido, A., Solis‐Urra, P., Osuna‐Prieto, F. J., & Ortega, F. B. (2024) · Pediatric Obesity · doi:10.1111/ijpo.13155 · Cited by 3
Cimiotti, C. G. V., Paganetti, P., Rossi, S., Soldini, E., & Sacco, L. (2023) · NeuroSci · doi:10.3390/neurosci4040026 · Cited by 3
Takeuchi, H. (2013) · Advances in Neuroimmune Biology · doi:10.3233/nib-130057 · Cited by 3
Metales de transición y enfermedad de Alzheimer
Opazo, C. (2005) · Revista Española de Geriatría y Gerontología · doi:10.1016/s0211-139x(05)74885-x · Cited by 3
Beta Amyloid Protein Clearance and Microglial Activation
Frautschy, S. A., Cole, G. M., & Ard, M. D. (2002) · Springer eBooks · doi:10.1007/978-1-4757-4139-1_12 · Cited by 3
The Role of Oxidative Stress in the Pathological Sequelae of Alzheimer Disease
Smith, M. A., & Perry, G. L. (1998) · Springer eBooks · doi:10.1007/978-1-4757-2907-8_19 · Cited by 3
6β-Acetoxy nortropane regulated processing of amyloid precursor protein in CHOm1 cells and rat brain
Qiu, Y. L., Chen, H., Wu, X.-J., & Jin, Z.-J. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01665-0 · Cited by 3
N’Go, P. K., Tehoua, L., Ahami, O. T. A., Azzaoui, F.-Z., & Aboussaleh, Y. (2021) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2220 · Cited by 2
HMGB1 signalling in Alzheimer’s disease: pathogenic roles and therapeutic prospects
Tyagi, P., Kumari, S., Sharma, P., Dhapola, R., Paidlewar, M., Medhi, B., & HariKrishnaReddy, D. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117204 · Cited by 2
Neurochemical Aspects of Alzheimer Disease
Farooqui, A. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-15889-1_1 · Cited by 2
New Perspectives in Reducing Amyloid Aggregation and Toxicity
Chemerovski‐Glikman, M., Richman, M., & Rahimipour, S. (2015) · Israel Journal of Chemistry · doi:10.1002/ijch.201500010 · Cited by 2
Targeting Aβ Receptors to Modify Alzheimer’s Disease Progression
Haas, L. T., & Strittmatter, S. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00008-3 · Cited by 2
Cellular and molecular mechanisms of Alzheimer’s disease inflammation
Peery, H. E., Strohmeyer, R., & Rogers, J. (2001) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8350-4_1 · Cited by 2
Calcium Signaling in Microglial Cells
Möller, T. (2002) · Springer eBooks · doi:10.1007/978-1-4757-4139-1_4 · Cited by 2
Kim, Y. A., Lim, S., Ko, W. S., Choi, B. T., Lee, Y. T., Rhee, S., Park, K., Lee, W.-H., & Choi, Y. H. (2005) · Journal of Life Science · doi:10.5352/jls.2005.15.2.169 · Cited by 2
The potential application of cyclo-oxygenase type 2 inhibitors to Alzheimer’s disease
Sandson, T. A., & Félician, O. (1998) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.7.4.519 · Cited by 2
CAA in Transgenic Mouse Models of Alzheimer’s Disease
Cole, G. M., & Yang, F. (2000) · Springer eBooks · doi:10.1007/978-94-017-1007-7_18 · Cited by 2
Chen, X., Wang, X., Li, C., Shan, K., Wang, L., Hashimoto, K., Shao, K., Wei, P., & Yang, J.-J. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106965 · Cited by 1
[The scavenger receptor and its importance in amyloid processes].
Aguilar-Gaytán, R., & Mas‐Oliva, J. (2002) · PubMed · Cited by 1
Sund, M. (2001) · Cited by 1
Pathological Validation of Animal Models of Dementia
Pirici, D. N., Broeckhoven, C. V., & Kumar‐Singh, S. (2010) · Neuromethods · doi:10.1007/978-1-60761-898-0_7 · Cited by 1
CD36: An Inflammatory Mediator in Acute Brain Injury
Cho, S., & Febbraio, M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8915-3_18 · Cited by 1
Boondam, Y., & Cheepsunthorn, P. (2014) · Asian Biomedicine · doi:10.5372/1905-7415.0802.299 · Cited by 1
Novel Somatostatin Receptor Subtype‐4 Agonist Mitigates Microglia Inflammatory Activation
Silwal, A., Mobayen, S., Crider, A. M., Neumann, W. L., House, A., Umbaugh, D. S., Bhandari, S., Sandoval, K. E., & WITT, K. A. (2019) · The FASEB Journal · doi:10.1096/fasebj.2019.33.1_supplement.501.3 · Cited by 1
Ikezu, T. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_30 · Cited by 1
Astrocytes and microgliain Alzheimer's disease
Barger, S. W. (2003) · Advances in molecular and cell biology · doi:10.1016/s1569-2558(03)31039-2 · Cited by 1
The Involvement of Aβ in the Neuroinflammatory Response
Eikelenboom, P., van Gool, W. A., Rozemüller, A. J. M., Scheper, W., Veerhuis, R., & Hoozemans, J. J. M. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_4 · Cited by 1
Regulation of the immune response within the central nervous system
Antel, J. P. (2001) · Neuroimmune biology · doi:10.1016/s1567-7443(01)80010-7 · Cited by 1
Developmental role and ligand binding properties of macrophage scavenger receptor MARCO
Chen, Y. (2006) · Figshare · Cited by 1
Role of macrophage receptor MARCO in host defense
Sankala, M. (2003) · Figshare · Cited by 1
Aging and Cognitive Decline: Neuroprotective Strategies
do Couto, F. S., & de Mendonça, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-70830-0_11 · Cited by 1
Heparan Sulfate in the Amyloidosis and Inflammation of Alzheimer’s Disease
O′Callaghan, P. W. (2011) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
Giordani, L., Mattioli, B., Quaranta, M. G., Giacomini, E., Libri, I., Varı́, R., Masella, R., & Viora, M. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.05.012 · Cited by 1
Microglial Responses in Alzheimer’s Disease
Walker, D. G., & Lue, L. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-297-5_13 · Cited by 1
Emerging strategies for the treatment of Alzheimer’s disease at the Millennium
Emmerling, M. R., Spiegel, K., Hall, E. D., LeVine, H., Walker, L. C., Schwarz, R. D., & Gracon, S. I. (1999) · Emerging Drugs · doi:10.1517/14728214.4.1.35 · Cited by 1
Dissection of the Class a Scavenger Receptor by Peptide Engineering
Suzuki, K. T., Takano, T. Y., & Tanaka, T. (1999) · Science Progress · doi:10.1177/003685049908200405 · Cited by 1
Arbez, N. (2005) · HAL · Cited by 1
BiP/GRP78-Induced Microglial Activation and Increase of Aß Clearance
Kitamura, Y., Kakimura, J., Taniguchi, T., Shimohama, S., & Gebicke‐Haerter, P. J. (2002) · Advances in behavioral biology · doi:10.1007/978-0-306-47593-1_39 · Cited by 1
Mead, E. (2012) · UCL Discovery (University College London) · Cited by 1
Activated Neuroglia in Alzheimer's Disease
Brunden, K. R., & Frederickson, R. C. A. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-105-3_20 · Cited by 1
Vascular Transport of Alzheimer’s Amyloid β Peptides and Apolipoproteins
Zloković, B. V., Ghiso, J. A., & Frangione, B. (2000) · Springer eBooks · doi:10.1007/978-94-017-1007-7_20 · Cited by 1
Hepburn, J. D. (2012) · Scholarship@Western (Western University)
Molecular Genetics and Molecular Biology of Alzheimer’s Disease
Sandbrink, R., & Beyreuther, K. T. (2001) · Springer eBooks · doi:10.1007/978-3-642-59519-6_72
Interaction of Synuclein and Inflammation in Dopaminergic Neurodegeneration
Przedborski, S. (2009) · Defense Technical Information Center (DTIC) · doi:10.21236/ada506349
Chapter 3 Structural Changes in the Aged Brain
Dickson, D. W. (1997) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(08)60053-x
Monocytes as Gene Therapy Vectors for the Treatment of Alzheimer’s Disease
Lebson, L. A. (2008) · Digital Commons - University of South Florida (University of South Florida)
Proposed Mechanism of Selective LCM Uptake by Tumor Cells
D'Arrigo, J. S. (2011) · Studies in interface science · doi:10.1016/b978-0-444-53798-0.00016-x
Karn, S., Wei, Z., MacTavish, D., Kabogo, D., Song, M.-S., & Jhamandas, J. H. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_10
Mikroglia bei Alzheimer-Demenz
Wiltfang, J. (2014) · Nervenheilkunde · doi:10.1055/s-0038-1627748
Sarlus, H. (2015) · Figshare
The implications of genetic studies on the pathogenesis of Alzheimer's disease
Sasaki, H. (1998) · Neuropathology · doi:10.1111/j.1440-1789.1998.tb00086.x
Pattern Recognition Receptors in CNS Disease
Carpentier, P. A., Duncan, D. S., & Miller, S. D. (2007) · Springer eBooks · doi:10.1007/978-0-387-73894-9_7
Cytokine Communication Between Neurons and Glia and the Pathogenesis of Alzheimer’s Disease
Cordell, B., Yang, L., Naidu, A., Bales, K. R., Paul, S. M., & Murphy, G. M. (2000) · Research and perspectives in neurosciences · doi:10.1007/978-3-642-59643-8_4
Multipotent neural stem/progenitor cells as a model of genetic neuronal diseases
Kärkkäinen, V. (2012) · UEF eRepo (University of Eastern Finland)
Barclay, A. N., Brown, M. H., Law, S. K. A., McKnight, A. J., Tomlinson, M. G., & van der Merwe, P. A. (1997) · Elsevier eBooks · doi:10.1016/b978-012078185-0/50633-8
Purification and characterisation of the ectodomain of the scavenger receptor CD36
Sanders, D. J. (2014)
Macrophage Scavenger Receptors and Atherosclerosis
Kodama, T. (1998) · Journal of the Japan Society of the Reticuloendothelial System · doi:10.3960/jslrt1997.38.261
Understanding and Exploiting Wnt5a and GSK3 Signaling in Inflammatory Disease
Bhatt, P. M. (2013) · OhioLink ETD Center (Ohio Library and Information Network)
Elucidating the effect of aggregated SOD1 on microglia and astrocytes in ALS
Roberts, K. (2016) · Research Online (University of Wollongong)
Donnou, S., & Couez, D. (2007) · OpenGrey (Institut de l'Information Scientifique et Technique)
Receptor Expression 7 Requires P2X β Activation of Microglia by Amyloid
Trabace, L., Idzko, M., Falzoni, S., Fellin, R., Sanz, J. M., Chiozzi, P., & Ferrari, D. (2012)
Njie, E. G. (2010) · University of Florida Digital Collections (University of Florida)
Mackenzie, I. R. (2001) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8350-4_11
Metadata
- Authors
- Khoury, J. E., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., & Loike, J. D.
- Affiliations
- Columbia University (US)
- Venue
- Nature
- Published
- 1996-08
- Volume
- 382
- Issue
- 6593
- Pages
- 716-719
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2045560271
- Cited by
- 727
- References
- 21
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 12 · 2023: 10 · 2022: 18 · 2021: 19 · 2020: 20 · 2019: 15 · 2018: 12 · 2017: 10 · 2016: 18 · 2015: 21 · 2014: 20 · 2013: 22 · 2012: 31
- FWCI
- 29.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- scavenger receptors, scavenger receptor A, microglia, amyloid-beta fibrils, Alzheimer's disease, amyloid plaques, reactive oxygen species, monocytes, cell immobilization, therapeutic target
- MeSH terms
- Alzheimer Disease, Amino Acid Sequence, Animals, Cell Adhesion, Cell Line, Cell Movement, Collagen, Humans, Ligands, Membrane Proteins, Molecular Sequence Data, Monocytes, Peptides, Receptors, Immunologic, Amyloid beta-Peptides, Reactive Oxygen Species, Microglia, Receptors, Lipoprotein, Receptors, Scavenger, Scavenger Receptors, Class A, Scavenger Receptors, Class B, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review